| Name | benzyl N-[(2R)-4-morpholin-4-yl-4-oxo-1-phenylsulfanylbutan-2-yl]carbamate |
|---|---|
| Synonyms |
(R)-benzyl 4-morpholino-4-oxo-1-(phenylthio)butan-2-ylcarbamate
N-Benzyloxycarbonyl-4-[(3R)-3-amino-1-oxo-4-(phenylthio)butyl]morpholine N-[(1R)-3-(4-Morpholinyl)-3-oxo-1-[(phenylthio)methyl]propyl]carbamic Acid Phenylmethyl Ester benzyl (1R)-3-(4-morpholinyl)-3-oxo-1-((phenylsulfanyl)methyl)propylcarbamate [(1R)-3-(4-Morpholinyl)-3-oxo-1-[(phenylthio)methyl]propyl]carbamic Acid Benzyl Ester |
| Molecular Formula | C22H26N2O4S |
|---|---|
| Molecular Weight | 414.51800 |
| Exact Mass | 414.16100 |
| PSA | 96.66000 |
| LogP | 3.46490 |
|
~74%
870812-93-4 |
| Literature: Elmore, Steven W.; Bruncko, Milan; Park, Cheol-Min Patent: US2005/272744 A1, 2005 ; Location in patent: Page/Page column 20 ; US 20050272744 A1 |
|
~46%
870812-93-4 |
| Literature: GENENTECH, INC.; WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH Patent: WO2008/61208 A2, 2008 ; Location in patent: Page/Page column 31; 33 ; WO 2008/061208 A2 |
|
~%
870812-93-4 |
| Literature: ASTRAZENECA AB Patent: US2012/35134 A1, 2012 ; |
|
~%
870812-93-4 |
| Literature: ASTRAZENECA AB Patent: US2012/35134 A1, 2012 ; |
|
~%
870812-93-4 |
| Literature: ASTRAZENECA AB Patent: US2012/35134 A1, 2012 ; |
|
~%
870812-93-4 |
| Literature: ASTRAZENECA AB Patent: US2012/35134 A1, 2012 ; |
| Precursor 6 | |
|---|---|
| DownStream 1 | |